WUXAY WuXi AppTec Co Ltd ADR Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
05:45
Aug 08
Aug 08
A US judge blocked the Defense Department from enforcing its designation of WuXi AppTec.
A US judge blocked the Defense Department from enforcing its designation of WuXi AppTec as a Chinese military company, granting temporary relief to the pharmaceutical contractor.
22:19
Aug 04
Aug 04
Strong earnings and irreplaceable position in GLP-1.
WuXi AppTec reported a 20% earnings beat for Q2, driven by strong growth in its CMO and CDMO businesses. The company holds a 25% market share in the global GLP-1 (obesity) drug supply chain, and its US revenue portion has increased to 77% despite US sanctions, demonstrating its irreplaceable market position.
HIGH
05:01
Aug 04
Aug 04
WuXi AppTec booms on obesity drug demand
WuXi AppTec delivered a very strong earnings beat driven by surging obesity drug demand from both oral and injectable GLP-1. Raised capex guidance indicates robust future demand. Despite geopolitical noise and potential generic competition, pricing is already very affordable, and the company continues to deliver essential scale and quality that global pharma depends on.
HIGH
About WUXAY Investor Commentary
Across the available history and selected sources, Buzzberg tracks WUXAY (WuXi AppTec Co Ltd ADR) across 3 sources: 2 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 50% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 4 total trade ideas tracked. Latest voices: Bloomberg, Wang, Cui Cui.